Zobrazeno 1 - 6 of 6 pro vyhledávání: '"Camila Morais Melo"'
1
Dissertation/ Thesis
Envolvimento das galectinas na angiogênese tumoral em modelo de melanoma murino e associação com o microambiente tumoral via receptores toll-like
Autor: Camila Morais Melo
Publikováno v: Biblioteca Digital de Teses e Dissertações da USPUniversidade de São PauloUSP.
O melanoma é a forma mais letal entre os cânceres de pele. Essa neoplasia freqüentemente apresenta-se resistente a abordagens terapêuticas. A angiogênese associada ao tumor representa um crítico passo da tumorigênese, resultado da ação de di
Externí odkaz: http://www.teses.usp.br/teses/disponiveis/5/5155/tde-06012016-135928/
Zobrazit plný text záznamu
3
The role of somatic mutations on the immune response of the tumor microenvironment in prostate cancer
Autor: Rodolfo Borges dos Reis, Jeremy A. Squire, Luiz Paulo Chaves, Thiago Vidotto, William Lautert-Dutra, Camila Morais Melo
Publikováno v: Repositório Institucional da USP (Biblioteca Digital da Produção Intelectual)
Universidade de São Paulo (USP)
instacron:USP
International Journal of Molecular Sciences, Vol 22, Iss 9550, p 9550 (2021)
International Journal of Molecular Sciences
Immunotherapy has improved patient survival in many types of cancer, but for prostate cancer, initial results with immunotherapy have been disappointing. Prostate cancer is considered an immunologically excluded or cold tumor, unable to generate an e
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b833ce6b7e73a2330bab52c3a0b383ea
Zobrazit plný text záznamu
4
Abstract 6099: Differential gene expression related to TMPRSS2-ERG fusion, CDK12, RB1, TP53, AR and ZEB1 based on transcriptomic analysis of the TCGA PRAD cohort
Autor: William Lautert-Dutra, Camila Morais Melo, Luiz Paulo Chaves, André Luiz Caliari, Francisco Cesar Souza Silva, Jeremy Andrew Squire
Publikováno v: Cancer Research. 82:6099-6099
Prostate Cancer (PCa) is considered an immunologically excluded tumor, unable to generate an effective T-cell response against cancer cells. Inactivating mutations of the PTEN tumor suppressor are one of the most common events in human malignancies t
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::3fc280399dbda54a271aabcc6d5eede0
https://doi.org/10.1158/1538-7445.am2022-6099
Zobrazit plný text záznamu
5
Abstract 6098: Analysis of the impact of ZEB1 expression on pathway enrichment and immune cell abundance in prostate cancer
Autor: Luiz Paulo Chaves, André Luiz Caliari, William Lautert-Dutra, Francisco Cesar Souza Silva, Camila Morais Melo, Fabiano Pinto Saggioro, Rodolfo Borges dos Reis, Jeremy Andrew Squire
Publikováno v: Cancer Research. 82:6098-6098
Prostate cancer (PCa) reactivates a latent embryonic program called epithelial-mesenchymal transition during disease progression. The mesenchymal phenotype contributes to invasion, metastasis and therapy response variation. In this study, we characte
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::d175f28f3864ba096122f839537a3b9a
https://doi.org/10.1158/1538-7445.am2022-6098
Zobrazit plný text záznamu
6
Emerging role of PTEN loss in evasion of the immune response to tumours
Autor: Thiago Vidotto, Rodolfo Borges dos Reis, Madhuri Koti, Erick Castelli, Camila Morais Melo, Jeremy A. Squire
Publikováno v: Repositório Institucional da USP (Biblioteca Digital da Produção Intelectual)
Universidade de São Paulo (USP)
instacron:USP
British Journal of Cancer
Mutations inPTENactivate the phosphoinositide 3-kinase (PI3K) signalling network, leading to many of the characteristic phenotypic changes of cancer. However, the primary effects of this gene on oncogenesis through control of the PI3K–AKT–mammali
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f8a24a60af4cc9b071a3d74b73fd8e3a
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje